Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Journal Article

Grau, Veronika, Zeuschner, Philip ORCID: 0000-0001-8898-6588, Immenschuh, Stephan ORCID: 0000-0003-3722-5791, Bockmeyer, Clemens Luitpold, Zell, Stefanie, Wittig, Juliane, Saeuberlich, Karen, Abbas, Mahmoud, Padberg, Winfried, Meyer-Schwesinger, Catherine, von Brandenstein, Melanie, Schlosser, Monika, Dieplinger, Georg, Galliford, Jack, Clarke, Candice ORCID: 0000-0001-8576-1017, Roufosse, Candice ORCID: 0000-0002-6490-4290 and Becker, Jan Ulrich ORCID: 0000-0003-2929-8085 (2016). Immune Complex-Type Deposits in the Fischer-344 to Lewis Rat Model of Renal Transplantation and a Subset of Human Transplant Glomerulopathy. Transplantation, 100 (5). S. 1004 - 1015. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1534-6080

Kohl, Tobias, von Brandenstein, Melanie, Stog, Andreas, Schlosser, Monika, Kuru, Timur H., Pfister, David, Fries, Jochen ORCID: 0000-0003-2054-6345 and Heidenreich, Axel (2018). Vimentin 3 and endothelin in prostate cancer. J. Clin. Oncol., 36 (6). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Loeser, Heike, von Brandenstein, Melanie, Herschung, Angela, Schlosser, Monika, Buettner, Reinhard and Fries, Jochen W. U. (2015). ET-1 Induced Downregulation of MRP2 via miRNA 133a-A Marker for Tubular Nephrotoxicity? Am. J. Nephrol., 41 (3). S. 191 - 200. BASEL: KARGER. ISSN 1421-9670

von Brandenstein, Melanie, Puetz, Katharina, Schlosser, Monika, Loeser, Heike, Kallinowski, Joachim P., Goedde, Daniel, Buettner, Reinhard, Stoerkel, Stefan and Fries, Jochen W. U. (2015). Vimentin 3, the New Hope, Differentiating RCC versus Oncocytoma. Dis. Markers, 2015. LONDON: HINDAWI LTD. ISSN 1875-8630

von Brandenstein, Melanie, Schlosser, Monika, Herden, Jan, Heidenreich, Axel, Stoerkel, Stefan and Fries, Jochen W. U. (2018). MicroRNAs as Urinary Biomarker for Oncocytoma. Dis. Markers. LONDON: HINDAWI LTD. ISSN 1875-8630

This list was generated on Sun Dec 10 07:33:09 2023 CET.